glp-1/gip/glucagon triple agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research retatrutide triple agonist glp-1 gip
Description
These groups do not represent contraindications for GLP-1RA therapy
A patient walked into the clinic, excited about the 15 pounds theyd lost in two months on their new GLP-1 medication
However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period
June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
This is the low-dose initiation phase where your body begins recognizing the medication
95% CI 0.61, 1.10) [40]
